Jacob Gottlieb is an American entrepreneur who works in the financial industry. He recently opened his latest hedge fund company, Altium Capital. Like his prior hedge fund, Visium Asset Management for which he was the chief investment officer, he invests exclusively in healthcare firms. He had to close down this prior firm because a number of rogue employees engaged in insider trading which tainted the entire company. After he wound down this firm he decided to get a fresh start by starting a new company.
He got interested in investing when he was quite young. Jacob Gottlieb says that he won a stock picking contest at his school when he was still a teenager. He was split between pursuing a career as a doctor or as an investor. He attended Brown University and studied economics, graduating Magna Cum Laude. He then attended NYU Medical School and earned an M.D. He completed his medical internship during which time he realized that he really didn’t want to work as a doctor. It was at this time that he decided to follow his true passion, investing, and he started working on Wall Street.
Jacob Gottlieb started out on Wall Street at Sanford C. Bernstein & Co. where he was a buy-side analyst. He continued to go to school during this time and in 2001 he earned his Certified Financial Analyst designation. His career next took him to Merlin Biomed Group and then on to Balyasny Asset Management. He was very successful at this company and before long he was the top earner. He started his first firm, Visium Asset Management, in 2005.
He now has an office located in New York City where he operates Altium Capital. He shares this office with two other financial firms, Bay City Capital and Iguana Healthcare Partners. His initial investments at Altium were in Sellas Life Sciences and Oramed Pharamaceuticals, Inc.